Authors: McLay, IM Halley, F Souness, JE McKenna, J Benning, V Birrell, M Burton, B Belvisi, M Collis, A Constan, A Foster, M Hele, D Jayyosi, Z Kelley, M Maslen, C Miller, G Ouldelhkim, MC Page, K Phipps, S Pollock, K Porter, B Ratcliffe, AI Redford, EJ Webber, S Slater, B Thybaud, V Wilsher, N

Citation: Im. Mclay et al., The discovery of RPR 200765A, a p38 MAP kinase inhibitor displaying a goodoral anti-arthritic efficacy, BIO MED CH, 9(2), 2001, pp. 537-554

Authors: Collis, AJ Foster, ML Halley, F Maslen, C McLay, IM Page, KM Redford, EJ Souness, JE Wilsher, NE

Citation: Aj. Collis et al., RPR203494 a pyrimidine analogue of the p38 inhibitor RPR200765A with an improved in vitro potency, BIOORG MED, 11(5), 2001, pp. 693-696

Authors: Pickett, SD McLay, IM Clark, DE

Citation: Sd. Pickett et al., Enhancing the hit-to-lead properties of lead optimization libraries, J CHEM INF, 40(2), 2000, pp. 263-272

Authors: Astles, PC Brown, TJ Halley, F Handscombe, CM Harris, NV Majid, TN McCarthy, C McLay, IM Morley, A Porter, B Roach, AG Sargent, C Smith, C Walsh, RJA

Citation: Pc. Astles et al., Selective ETA antagonists. 5. Discovery and structure-activity relationships of phenoxyphenylacetic acid derivatives, J MED CHEM, 43(5), 2000, pp. 900-910